Back to search

Article

Cross-Cohort Evaluation of NanoString nCounter Data for Recurrence Prediction in Colorectal Cancer

2026-08-17

Abstract excerpt

Gene expression-based prognostic models have shown promise for predicting recurrence in colorectal cancer (CRC), but their clinical implementation remains limited. The NanoString nCounter platform provides a practical alternative to RNA sequencing and microarrays through standardized, cost-effective gene expression profiling that is compatible with routine clinical samples. In this study, we evaluated whether Nano...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0195be74-8119-51c2-a0ce-8d40edd32026
DOI
10.64898/2026.08.13.26360359
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cross-Cohort Evaluation of NanoString nCounter Data for Recurrence Prediction in Colorectal CancerDOI 10.64898/2026.08.13.26360359
Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal CancerSemantic proximity
A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.Semantic proximity
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.Semantic proximity
Integrative bulk and single-cell transcriptomics identify a recurrence-prognostic risk model with exploratory associations with treatment-response phenotypes in colorectal cancer.Semantic proximity
A network‐based predictive gene expression signature for recurrence risks in stage II colorectal cancerSemantic proximity
Transcriptomic profiling reveals an enhancer RNA signature for recurrence prediction in colorectal cancerSemantic proximity
Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stages I-III colorectal cancerSemantic proximity
A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.Semantic proximity
Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal CancerSemantic proximity
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular SubtypesSemantic proximity
Integrative bulk and single-cell transcriptomics identify a chemoresistance-related risk model for recurrence prediction in colorectal cancerSemantic proximity
Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancerSemantic proximity
Select a neighboring publication to make it the new centre.